Search
Now showing items 1-10 of 44
-
Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases.
WHO interim guidelines recommend offering extracorporeal membrane oxygenation (ECMO) to eligible patients with acute respiratory distress syndrome (ARDS) related to coronavirus disease 2019 (COVID-19). The number of patients ... -
Disability considerations during the COVID-19 outbreak
(2020-03-26)Considerations for actors: Actions for people with disability and their household Reduce your potential exposure to COVID-19. Everyone with disability and their household should follow the WHO guidance on basic protection ... -
Preparing for a COVID-19 pandemic: a review of operating room outbreak response measures in a large tertiary hospital in Singapore
(2020-03-11)The coronavirus disease 2019 (COVID-19) outbreak has been designated a public health emergency of international concern. To prepare for a pandemic, hospitals need a strategy to manage their space, staff, and supplies so ... -
Chloroquine and hydroxychloroquine: Current evidence for their effectiveness in treating COVID-19
(2020-03-25)Verdict: Several in vitro studies report antiviral activity of chloroquine and hydroxychloroquine against SARS-CoV-2. In vivo data, although promising, is currently limited to one study with considerable limitations. On ... -
Coronavirus in Pregnancy and Delivery: Rapid Review and Expert Consensus
(2020-03-08)BACKGROUND Person to person spread of COIVD-19 in the UK has now been confirmed. There are limited case series reporting the impact on women affected by coronaviruses (CoV) during pregnancy. In women affected by SARS and ... -
Rapidly managing pneumonia in older people during a pandemic
(2020-03-20)The current COVID-19 pandemic has highlighted the risk faced by older adults, who are more susceptible to complications, including acute respiratory distress syndrome, usually as a result of pneumonia. Comorbidities, ... -
Of Chloroquine and COVID-19
Recent publications have brought attention to the possible benefit of chloroquine, a broadly used antimalarial drug, in the treatment of patients infected by the novel emerged coronavirus (SARS-CoV-2). The scientific ... -
La médecine chinoise pour le traitement du SARS
(2020-04-14)Citation: Leung, PC. The efficacy of Chinese medicine for SARS: a review of Chinese publications after the crisis. American Journal of Chinese Medicine 2007; 35(4): 575-81 De quoi s’agit-il ? Comme le COVID-19, le syndrome ... -
Mathematical model of infection kinetics and its analysis for COVID-19, SARS and MERS
(2020-04-08)The purpose of this paper is to reveal the spread rules of the three pneumonia: COVID-19, SARS and MERS. We compare the new spread characteristics of COVID-19 with those of SARS and MERS. By considering the growth rate and ...